Jun 25, 2019 / 12:30PM GMT
Operator
Good day and thank you for standing by. Welcome to the AbbVie Investor and Analyst Conference Call. (Operator Instructions) This call is being recorded by AbbVie.
I would now like to introduce Ms. Liz Shea, Vice President of Investor Relations.
Elizabeth Shea - AbbVie Inc. - VP of IR
Good morning, and thanks for joining us for this special conference call to discuss AbbVie's acquisition of Allergan, which we announced this morning.
Joining me on the call today are Rick Gonzalez, Chairman of the Board and Chief Executive Officer; and Rob Michael, Senior Vice President and Chief Financial Officer. Joining us for the Q&A portion of the call are Michael Severino, Vice Chairman and President; Laura Schumacher, Vice Chairman, External Affairs, Chief Legal Officer and Corporate Secretary; Bill Chase, Executive Vice President of Finance and Administration; and Henry Gosebruch, Executive Vice President and Chief Strategy Officer.
Rick will provide an overview of the strategic rationale for this acquisition, and Rob will discuss the key
AbbVie Inc to Acquire Allergan plc - M&A Call Transcript
Jun 25, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers